Familial amyloidosis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Familial amyloidosis}} | {{Familial amyloidosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Fs}} | ||
==Overview== | ==Overview== | ||
Common [[Risk factor|risk factors]] in the development of familial amyloidosis include older age, [[male]] gender, african american race, and positive [[family history]]. | Common [[Risk factor|risk factors]] in the development of familial amyloidosis include older age, [[male]] gender, african american race, and positive [[family history]]. | ||
Revision as of 20:23, 25 November 2019
|
Familial amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Familial amyloidosis risk factors On the Web |
|
American Roentgen Ray Society Images of Familial amyloidosis risk factors |
|
Risk calculators and risk factors for Familial amyloidosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Common risk factors in the development of familial amyloidosis include older age, male gender, african american race, and positive family history.
Risk Factors
Common Risk Factors
- Common risk factors in the development of familial amyloidosis include:[1][2][3]
- Older age
- Male gender
- African american race
- Positive family history
References
- ↑ Shin YM (March 2011). "Hepatic amyloidosis". Korean J Hepatol. 17 (1): 80–3. doi:10.3350/kjhep.2011.17.1.80. PMC 3304630. PMID 21494083.
- ↑ Khan MF, Falk RH (November 2001). "Amyloidosis". Postgrad Med J. 77 (913): 686–93. PMC 1742163. PMID 11677276.
- ↑ Shin YM (March 2011). "Hepatic amyloidosis". Korean J Hepatol. 17 (1): 80–3. doi:10.3350/kjhep.2011.17.1.80. PMC 3304630. PMID 21494083.